Evolving Care of Heavily Treatment–Experienced Patients With HIV

In this call between colleagues, expert faculty discuss their approaches to assessing virologic failure in a patient with an extensive but incomplete treatment history, including recommendations on assessing adherence and determining which resistance tests are needed.

Princy N. Kumar, MD, FIDSA, MACP Brian Wood, MD Physicians: maximum of 0.5 AMA PRA Category 1 Credits™ Pharmacists: 0.5 contact hours (0.05 CEUs) Released: February 22, 2021 Expired: February 21, 2022

In this call between colleagues, expert faculty discuss how they approach ART optimization in a virologically suppressed patient with HIV and multiclass resistance, including a discussion of relevant guidelines and data.

Roger Bedimo, MD, MS, FACP David A. Wohl, MD Physicians: maximum of 0.5 AMA PRA Category 1 Credits™ Pharmacists: 0.5 contact hours (0.05 CEUs) Released: March 24, 2021 Expired: March 23, 2022

In this call between colleagues, expert faculty discuss how they select next-line ART for a heavily treatment–experienced patient with multiclass drug resistance experiencing virologic failure; discussion includes current and future options for treating patients with multiclass drug resistance.

Joseph J. Eron, Jr., MD Monica Gandhi, MD, MPH Physicians: maximum of 0.5 AMA PRA Category 1 Credits™ Pharmacists: 0.5 contact hours (0.05 CEUs) Released: April 19, 2021 Expired: April 18, 2022

Download this expert-authored slideset to review guidelines and key data on assessing virologic failure for patients with multiclass drug resistance.

Princy N. Kumar, MD, FIDSA, MACP Brian Wood, MD Released: February 22, 2021

Download this expert-authored slideset to review guidelines and key data on switching ART in a heavily-treatment experienced patient with HIV and multiclass drug resistance.

Roger Bedimo, MD, MS, FACP David A. Wohl, MD Released: March 24, 2021

Download this expert-authored slideset to review guidelines and key data on selecting next-line ART for a heavily-treatment experienced patient with multiclass drug resistance experiencing virologic failure.

Joseph J. Eron, Jr., MD Monica Gandhi, MD, MPH Released: April 19, 2021

Heavily treatment–experienced patients with HIV are increasingly less common. However, by nature these patients are more complex and challenging. Here are expert answers to your outstanding questions on managing these patients.

Roger Bedimo, MD, MS, FACP Princy N. Kumar, MD, FIDSA, MACP Brian Wood, MD Released: June 2, 2021

In this podcast, listen to Roger Bedimo, MD, MS, FACP; Princy N. Kumar, MD, FIDSA, MACP; and Brian Wood, MD, answer healthcare professionals’ questions on care of heavily treatment–experienced patients with HIV, including which assessments are needed and how to best incorporate the latest approved treatment options.

Roger Bedimo, MD, MS, FACP Princy N. Kumar, MD, FIDSA, MACP Brian Wood, MD Released: June 15, 2021